By Sola Ogundipe
A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania have identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other diseases.
The team, whose findings are published in Cell Reports, screened thousands of existing drugs and drug-like molecules for the ability to inhibit the replication of the COVID-19 virus.
Of the nine drugs found to reduce the replication in respiratory cells, three already have FDA approval
“Our discoveries here suggest new avenues for therapeutic interventions against COVID-19, and also underscore the importance of testing candidate drugs in respiratory cells,” said Dr Sara Cherry, a professor of Pathology and Laboratory Medicine and scientific director of the High-Throughput Screening (HTS) Core at Penn Medicine.
Although great progress has been made in…